Vraylar is one of the small number of prescriptions where the monthly cash price is larger than most people’s rent. Medicare Part D covered 766,962 Vraylar claims for 117,573 people in 2024 at an average of $1,481.13 per claim, which added up to $1.14 billion for a single brand. Nobody in that dataset paid the full amount out of pocket. A cash payer does.
The reason is simple and it is not going to change this year: cariprazine has no generic. Every other lever on this page is secondary to that one fact. Everything below was researched on September 4, 2026, and the sources are named where each figure appears.
What Does Vraylar Cost Without Insurance?
Acquisition costs come from the CMS National Average Drug Acquisition Cost survey, effective August 19, 2026. That is what a pharmacy pays a wholesaler, not what you are quoted at the counter, and the gap between the two is part of the story. The list price comes from AbbVie’s own cost page. Cash prices come from Drugs.com and SingleCare, both read September 4, 2026.
| Option | Low | Average | High |
|---|---|---|---|
| CMS NADAC acquisition cost, one capsule | $50.77776 (6 mg) | $50.84553 (1.5 mg) | $50.89104 (0.75 mg) |
| CMS NADAC acquisition cost, 30 capsules | $1,523.33 (6 mg) | $1,525.37 (1.5 mg) | $1,526.73 (0.75 mg) |
| AbbVie published list price (WAC), 30-day supply | $1,594.82 | $1,594.82 | $1,594.82 |
| Cash price, 30 capsules, any strength (Drugs.com) | $1,565.72 | $1,565.72 | $1,565.72 |
| Cash price, 20-capsule pack, 1.5 mg and 3 mg only | $1,046.45 | $1,046.45 | $1,046.45 |
| Discount card price, 30 capsules of 1.5 mg | $1,463.03 | $1,463.03 | $1,463.03 |
| Average retail, 30 capsules of 1.5 mg, no card | $2,136.24 | $2,136.24 | $2,136.24 |
| Medicare Part D average paid per claim, 2024 | $1,481.13 | $1,481.13 | $1,481.13 |
| For contrast: 30 generic aripiprazole tablets (acquisition cost) | $3.10 (2 mg) | $3.75 (15 mg) | $5.02 (20 mg) |
The sources do not agree, and the spread is worth naming. AbbVie’s list price of $1,594.82 sits about $71 above what CMS says a pharmacy pays for 30 capsules and about $29 above what Drugs.com quotes a cash customer. SingleCare’s stated average retail price of $2,136.24 is roughly $540 above the list price, which tells you that some pharmacies mark this drug up well past what the manufacturer charges. Treat $1,463 to $2,136 as the realistic band and treat anything above $2,200 as a reason to call another pharmacy.
One quirk is worth knowing. Drugs.com lists a 20-capsule pack at $1,046.45 for the 1.5 mg and 3 mg strengths only, which works out to $52.32 per capsule against $52.19 in the 30-count. The smaller pack is not cheaper per capsule, it is just a smaller bill.
What Drives the Price
No generic, which is the entire story. Drugs.com states that Vraylar is a brand name drug only with no generic yet available. CMS’s acquisition-cost file agrees mechanically: search it for CARIPRAZINE and you get zero rows, while VRAYLAR returns all six strengths. Compare that with generic quetiapine at $0.02293 to $0.15480 per tablet in the same file, which is why our Seroquel cost guide lands on $9 to $15 a month while this page lands on four figures.
Dose is almost irrelevant. Vraylar runs from 0.5 mg to 6 mg, a twelvefold range, and the pharmacy’s acquisition cost moves by about eleven cents across all of it. Drugs.com quotes the same $1,565.72 for 30 capsules at every strength. If your dose goes up, your bill does not.
Whether anyone runs a discount card. The difference between SingleCare’s $2,136.24 average retail figure and its own $1,463.03 card price on the identical fill is $673 a month, which is larger than every other decision on this page except insurance itself. Our comparison of GoodRx vs. SingleCare covers how to price the same prescription both ways.
Which pharmacy you walk into. Per-pharmacy quotes for this drug move between visits and between chains, and discount-card sites publish chain-level prices that are not stable enough to quote as fact. The stable numbers are the average and the card price, and the distance between them is the argument for calling three pharmacies before you fill.
Whether you have any coverage at all. Part D paid an average of $1,481.13 per claim in 2024 and the patient paid a copay. A cash payer pays the whole quoted number. That is the single biggest fork on this page and it is why the assistance section below matters more than the shopping section.
Cash Price vs. Insurance
On most generics, paying cash beats using insurance. On Vraylar it almost never does. A commercial plan that covers Vraylar plus AbbVie’s savings card can take the copay to as little as $0, up to a $10,000 annual maximum per calendar year, and no cash price in the table comes close to that.
Read the card terms before you count on it, though, because they are narrower than the marketing. AbbVie’s program terms, read September 4, 2026, say the offer is not valid for cash-paying patients and is void for anyone enrolled in Medicare, Medicaid or another federal or state program. If you have commercial insurance but the plan does not cover Vraylar, the card falls to as little as $40 for up to two 30-day fills, per lifetime. That is a bridge, not a solution. AbbVie also notes that patients residing in or treated in certain states may not be eligible.
This is also the page where the deductible math flips. Because a cash fill does not count toward a deductible or out-of-pocket maximum, and because a single Vraylar fill is a meaningful chunk of most deductibles, running this drug through a plan is usually worth more than the discount you would get by paying cash. If you are weighing coverage options at all, our guide to self-pay vs. health insurance walks through the tradeoff.
How to Pay Less
-
Apply to myAbbVie Assist first if you are uninsured. This is the program built for exactly this situation, and it is the only route on this page that can take the cost to zero. AbbVie’s published income criteria, read September 4, 2026, cap annual household income at $63,840 for one person, $86,560 for two, $109,280 for three and $132,000 for four, plus $22,720 for each additional dependent. Vraylar appears on AbbVie’s list of covered medicines. The program line is 1-800-222-6885. One catch to know: patients whose commercial plan requires them to apply as a condition of coverage are not eligible.
-
Run a free discount card on every fill, even a brand-only one. SingleCare’s Vraylar page, prices updated September 4, 2026, showed $1,463.03 for 30 of the 1.5 mg capsules against a stated $2,136.24 average retail price. Cards do not usually do much on brand drugs, and $673 a month is an unusually large exception. Check before every refill rather than assuming last month’s number holds.
-
Price the same prescription at three pharmacies. The distance between AbbVie’s $1,594.82 list price and SingleCare’s $2,136.24 average retail is pharmacy markup, and it is negotiable in the sense that you can walk. Our fair price checker is a fast way to sanity-check a quote before you hand over a card.
-
Ask the prescriber what a 90-day script would do. AbbVie’s card language covers both 30-day and 90-day fills, and cash pharmacies charge their fixed costs per fill rather than per capsule. This is a question to raise at a visit, not a change to make on your own.
-
Ask whether an older molecule in the same class is appropriate for you. Generic aripiprazole cost Medicare Part D an average of $63.80 per claim in 2024 across 3.84 million claims, against $1,481.13 for Vraylar. That is a clinical decision and only your prescriber can make it, but it is a fair question to raise, and our Abilify cost guide and antidepressant cost guide cover what the cheaper shelf actually costs. The brand-only neighbours are priced the same way Vraylar is, as our Rexulti cost guide and Caplyta cost guide show. Never stop or change an antipsychotic on your own.
-
Budget for the prescriber, and use the cheap door if you need one. Vraylar requires an ongoing prescribing relationship and prior authorizations are common. Our psychiatrist cost guide covers visit prices, and a free or sliding-scale clinic can often handle the prescribing side at little or no cost while the assistance application is pending.
-
If a bill has already landed, deal with the bill. A single month of Vraylar can arrive as a four-figure pharmacy charge. Our guide to negotiating medical bills covers what to say, and hospital charity care applies if the prescription came out of a hospital or health-system pharmacy.
Bottom Line
Budget $1,463 to $2,136 for a 30-capsule month of Vraylar as a cash payer in September 2026, with about $1,566 as the middle of the range and no meaningful discount for a lower dose. AbbVie’s own published list price is $1,594.82 per 30-day supply as of January 2026.
If you have no insurance, the shopping tactics above will save you a few hundred dollars and myAbbVie Assist can save you everything, so make the assistance application the first call rather than the last. If you have commercial coverage, the savings card is worth up to $10,000 a year, and it is the only reason this drug is affordable for anyone. And if a four-figure pharmacy quote has already turned into a bill, our itemized bill guide is the place to start.